Pharmacological Activities of Turmerones

Amirhossein      Niknejad; Yasamin      Hosseini; Zahra      Najafi Arab; Seyed   Mehrad   Razavi; Saeideh      Momtaz; Thozhukat      Sathyapalan; Muhammed      Majeed; Tannaz      Jamialahmadi; Amir   Hossein   Abdolghaffari; Amirhossein      Sahebkar

doi:10.2174/0929867331666230907112441

Note! Please note that this article is currently in the "Article in Press" stage and is not the final "Version of record". While it has been accepted, copy-edited, and formatted, however, it is still undergoing proofreading and corrections by the authors. Therefore, the text may still change before the final publication. Although "Articles in Press" may not have all bibliographic details available, the DOI and the year of online publication can still be used to cite them. The article title, DOI, publication year, and author(s) should all be included in the citation format. Once the final "Version of record" becomes available the "Article in Press" will be replaced by that.

Abstract

Turmerones are major bioactive compounds of Curcuma species with several beneficial pharmacological activities. In addition, various in vivo and in vitro studies noted that turmerones could affect different cytokines, metabolic pathways, and targets. Turmerones will have the potential to be a candidate agent to lessen many pathological and immunological conditions as a result of these pharmacological activities. In this review, we provided information about the pharmacological actions of turmerones using search engines such as PubMed, Google Scholar, Scopus, and Web of Science.

Keywords: Turmerones, Curcuma species, anti-inflammatory, neuroprotection, anticancer

Rights & Permissions Print Cite

Current Medicinal Chemistry

Title:Pharmacological Activities of Turmerones

Volume: 31

Author(s): Amirhossein Niknejad, Yasamin Hosseini, Zahra Najafi Arab, Seyed Mehrad Razavi, Saeideh Momtaz, Thozhukat Sathyapalan, Muhammed Majeed, Tannaz Jamialahmadi, Amir Hossein Abdolghaffari and Amirhossein Sahebkar*

Affiliation:

Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

Keywords: Turmerones, Curcuma species, anti-inflammatory, neuroprotection, anticancer

Abstract: Turmerones are major bioactive compounds of Curcuma species with several beneficial pharmacological activities. In addition, various in vivo and in vitro studies noted that turmerones could affect different cytokines, metabolic pathways, and targets. Turmerones will have the potential to be a candidate agent to lessen many pathological and immunological conditions as a result of these pharmacological activities. In this review, we provided information about the pharmacological actions of turmerones using search engines such as PubMed, Google Scholar, Scopus, and Web of Science.

Export Options

Export File:

RIS (for EndNote, Reference Manager, ProCite)

BibTeX

Text

Content:

Citation Only

Citation and Abstract

About this article

Cite this article as:

Niknejad Amirhossein, Hosseini Yasamin, Najafi Arab Zahra, Razavi Mehrad Seyed, Momtaz Saeideh, Sathyapalan Thozhukat, Majeed Muhammed, Jamialahmadi Tannaz, Abdolghaffari Hossein Amir and Sahebkar Amirhossein*, Pharmacological Activities of Turmerones, Current Medicinal Chemistry 2024; 31 () . https://dx.doi.org/10.2174/0929867331666230907112441

DOI https://dx.doi.org/10.2174/0929867331666230907112441	Print ISSN 0929-8673
Publisher Name Bentham Science Publisher	Online ISSN 1875-533X

About this journal

Call for Papers in Thematic Issues

Submission closes on : 31 December, 2025

Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.

The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more

Guest Editor(s): Dr. Geir Bjørklund

Submission closes on : 31 December, 2025

Approaches to the Treatment of Chronic Inflammation

Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more

Guest Editor(s): Dr. Vladimir Rogovskii

Submission closes on : 31 December, 2025

Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications

The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more

Guest Editor(s): Dr. Igor A. Sobenin

Submission closes on : 31 December, 2025

Chalcogen-modified nucleic acid analogues

Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more

Guest Editor(s): Dr. Katarzyna Kulik